NEW YORK — Finn Partners has further expanded its healthcare practice with the addition of a new medical and scientific advisor alongside senior leadership moves.

The agency has brought onboard Joseph Hulihan, MD, who spent 15 years with Johnson & Johnson in neuroscience drug development and medical affairs, to provide medical insights on disease awareness and product and scientific communications. 

His medical and scientific input and guidance also will ensure content is medically accurate and compliant with regulatory requirements and valuable to patient communities.

Finn Partners also made executive moves within the practice.

Michael Heinley, who has been partner and deputy of the New York health group since 2016, was promoted to senior partner in recognition of his contribution to the practice and its growth. Heinley manages client teams spanning biopharma, medical devices, diagnostics, and advocacy organizations.

Additionally, Ann Hemingway has been hired as a partner in the New York health group, where she will continue her focus on pharmaceutical product communications including the development, launch and management of programs and cross-functional teams on a large scale including multiple geographies and disciplines.

She joins from Edelman where, as a senior VP, she oversaw several portfolios of business and integrated communication campaigns. Hemingway also has worked at Ogilvy and Havas. 

"As Finn continues to experience industry-leading growth, we recognized the need to expand our senior leadership team, and our capabilities to address the significant opportunity to meet the needs of client and the patient communities,” said Kristie Kuhl, who was promoted to New York and Chicago’s health practice managing partner last week.  “We’re thrilled to recognize the contributions of leaders such as Michael Heinley, and to strengthen Finn client services with seasoned industry pros Ann Hemingway and Dr. Hulihan.”